Integrated clinical development

We connect clinical, regulatory and pharmaco-economic expertise to turn scientific data into a robust, compliant and value-driven development strategy.

Data Review and Synthesis

Every sound strategy begins with sound evidence.

We conduct a complete comprehensive review of available preclinical and clinical data.

When appropriate, we apply advanced data-mining methods to uncover patterns or risks including safety signals that can inform next-phase decisions.

Key Efficacy and Safety Insights

Based on the data review, we extract and interpret the most relevant efficacy and safety insights.

Those form the scientific storyline of the customer’s program and guide both clinical strategy and regulatory positioning.

We ensure that safety observations are contextualized and that efficacy data support clear clinical differentiation.

Building the Core Storylines

A persuasive development strategy is built on three aligned narratives:

Efficacy – Demonstrating clinical benefit and scientific validity while addressing an unmet need.

Safety – Ensuring that all data are understood, mitigated framing risk within regulatory expectations.

Market & HEOR – Defining value proposition, differentiation against available therapies , and reimbursement rationale.

Together, these narratives create a compelling and coherent development story that links science, safety and value.

Integration into a Unified Dossier

The final step is the creation of an integrated dossier that connects all dimensions of development. It includes a robust clinical story, a regulatory-ready submission package, and a value dossier demonstrating incremental benefit over existing standards of care.
‍
Our multidisciplinary approach ensures that each element — from clinical summaries to economic models — tells a consistent, evidence-based story.
‍
We help assembling a fully integrated evidence package – from clinical summaries to value dossiers – ensuring consistency, clarity, and regulatory readiness across all components.

Why choose our integrated model

Scientific precision

Our recommendations are grounded in data, guided by decades of experience in clinical development, regulatory science, and pharmaco-economics.

Seamless collaboration

Innovation happens at the intersection of disciplines. Our integrated model eliminates silos and enables faster, more aligned decision-making.

Proven results

Our track record includes dozens of successful submissions and label extensions proof that our integrated approach consistently delivers measurable outcomes for patients, regulators and investors alike.

Related expertise

Our integrated approach brings together specialized expertise across every dimension of drug development.
Each area reinforces the next, ensuring your project advances with consistency and precision.

Clinical development and medical affairs
Regulatory strategy and submissions
Pharmaco-economics and market access
Safety analytics and data mining
Portfolio & business and portfolio-strategy
Due diligence

Let’s design your integrated development plan.